iShares US Pharmaceuticals ETF
IHE
IHE
92 hedge funds and large institutions have $83.8M invested in iShares US Pharmaceuticals ETF in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
1% less funds holding
Funds holding: 93 → 92 (-1)
Holders
92
Holding in Top 10
–
Calls
$1.55M
Puts
$525K
Top Buyers
| 1 | +$5.29M | |
| 2 | +$3.26M | |
| 3 | +$2.43M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.31M |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
+$1.21M |
Top Sellers
| 1 | -$996K | |
| 2 | -$868K | |
| 3 | -$493K | |
| 4 |
ST
Spinnaker Trust
Portland,
Maine
|
-$459K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$357K |